安徽长江药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
168
NMPA:168
Drug Approvals
Phenylephrine Hydrochloride Injection
- Product Name
- 盐酸去氧肾上腺素注射液
- Approval Number
- 国药准字H20254136
- Approval Date
- May 13, 2025
NMPA
Bupivacaine Hydrochloride Injection
- Product Name
- 盐酸布比卡因注射液
- Approval Number
- 国药准字H20258019
- Approval Date
- Feb 19, 2025
NMPA
Metoclopramide Hydrochloride Injection
- Product Name
- 盐酸甲氧氯普胺注射液
- Approval Number
- 国药准字H20249646
- Approval Date
- Dec 1, 2024
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20247162
- Approval Date
- Jul 12, 2024
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H20247152
- Approval Date
- Jul 8, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20234402
- Approval Date
- Oct 27, 2023
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20234401
- Approval Date
- Oct 27, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found